ELV · Elevance Health Inc.
$300.742026-05-17Sector: Healthcare; Industry: Medical - Healthcare Plans; Sub-Industry: Managed Health Care
Intrinsic Value Range Comparison · Mulya.ai
Very High Uncertainty
Base · active
$60
-80.2% vs market
Mulya.ai vs Analyst IV Comparison?
Mulya.ai IV range ($67 · $461) Analysts Range ($332 · $425) Fundamentals · historical + forward · baseitalics = DCF projection
| Period | Revenue | Rev Gr ? | Ops M% ? | Tax Rate ? | NOPAT ? | Reinvest ? | FCFF ? | WACC% ? | PV FCFF ? | ROIC ? | Inv. Cap ? | EPS ? | P/E |
|---|
| 2021.Q4 | $138.6B | — | 6.5% | 23.1% | $6.9B | −$1.6B | $5.2B | 4.4% | — | 12.5% | $55.2B | $27.52 | — |
| 2022.Q4 | $156.6B | 13.0% | 5.4% | 22.5% | $6.5B | $168MM | $6.7B | 6.0% | — | 12.0% | $53.9B | $26.57 | — |
| 2023.Q4 | $171.3B | 9.4% | 5.1% | 22.3% | $6.8B | −$1.6B | $5.2B | 5.9% | — | 12.1% | $58.7B | $26.99 | — |
| 2024.Q4 | $176.8B | 3.2% | 5.0% | 24.5% | $6.7B | −$6.0B | $686MM | 6.5% | — | 10.8% | $65.1B | $26.96 | — |
| 2025.Q4 | $199.1B | 12.6% | 4.1% | 15.6% | $6.8B | −$2.8B | $4.1B | 6.4% | — | 10.4% | $67.1B | $25.53 | 8.2 |
| italics below = DCF projection · 10yr Rev CAGR: 3.5% |
| 2026.Q4 | $193.1B | +-3.0% | 4.1% | 16.1% | $6.6B | $0MM | $6.6B | 6.7% | $6.2B | 9.9% | $67.1B | $29.84 | 10.1 |
| 2027.Q4 | $197.1B | +2.1% | 4.1% | 16.5% | $6.7B | −$125MM | $6.6B | 6.9% | $5.8B | 10.0% | $67.2B | $30.31 | 9.9 |
| 2028.Q4 | $208.2B | +5.7% | 4.1% | 16.9% | $7.1B | −$629MM | $6.4B | 7.1% | $5.3B | 10.5% | $67.8B | $31.85 | 9.4 |
| 2029.Q4 | $219.9B | +5.6% | 4.1% | 17.4% | $7.4B | $0MM | $7.4B | 7.3% | $5.7B | 10.9% | $67.8B | $33.46 | 9.0 |
| 2030.Q4 | $229.5B | +4.3% | 4.1% | 17.8% | $7.7B | −$39.7B | −$32.0B | 7.5% | −$22.7B | 8.8% | $107.5B | $34.73 | 8.7 |
|
| Term. Yr+ | $293.4B | 4.1% | 3.3% | 20.0% | $7.8B | −$3.7B | $4.1B | 8.6% | $43.7B | 8.6% | — | — | — |
Active scenario IV: $60 (-80.2% vs market)